U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C6H11FO5
Molecular Weight 182.1469
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of .ALPHA.-D-FLUDEOXYGLUCOPYRANOSE

SMILES

OC[C@H]1O[C@H](O)[C@H](F)[C@@H](O)[C@@H]1O

InChI

InChIKey=ZCXUVYAZINUVJD-UKFBFLRUSA-N
InChI=1S/C6H11FO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1H2/t2-,3-,4-,5-,6+/m1/s1

HIDE SMILES / InChI

Molecular Formula C6H11FO5
Molecular Weight 182.1469
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Fludeoxyglucose F-18 is a positron emitting radiopharmaceutical that is used for diagnostic purposes in conjunction with positron emission tomography (PET) imaging.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
FLUDEOXYGLUCOSE F18

Approved Use

For positron emission tomography (PET) imaging in oncology, cardiology, neurology.

Launch Date

2005
Diagnostic
FLUDEOXYGLUCOSE F18

Approved Use

For positron emission tomography (PET) imaging in oncology, cardiology, neurology.

Launch Date

2005
Diagnostic
FLUDEOXYGLUCOSE F18

Approved Use

For positron emission tomography (PET) imaging in oncology, cardiology, neurology.

Launch Date

2005
Diagnostic
FLUDEOXYGLUCOSE F18

Approved Use

For positron emission tomography (PET) imaging in oncology, cardiology, neurology.

Launch Date

2005
PubMed

PubMed

TitleDatePubMed
Disseminated histoplasmosis demonstrated on F18-fluorodeoxyglucose positron emission tomography/computed tomography in a renal transplant recipient.
2016 Apr-Jun
Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography.
2016 Aug
Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
2016 Aug

Sample Use Guides

5 – 10 mCi (adults), 2.6 mCi (pediatric patients)
Route of Administration: Intravenous
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 14:05:32 GMT 2023
Edited
by admin
on Sat Dec 16 14:05:32 GMT 2023
Record UNII
H0QPM375HE
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
.ALPHA.-D-FLUDEOXYGLUCOPYRANOSE
Common Name English
.ALPHA.-D-GLUCOPYRANOSE, 2-DEOXY-2-FLUORO-
Common Name English
Code System Code Type Description
CAS
62182-10-9
Created by admin on Sat Dec 16 14:05:32 GMT 2023 , Edited by admin on Sat Dec 16 14:05:32 GMT 2023
PRIMARY
PUBCHEM
445226
Created by admin on Sat Dec 16 14:05:32 GMT 2023 , Edited by admin on Sat Dec 16 14:05:32 GMT 2023
PRIMARY
DRUG BANK
DB04282
Created by admin on Sat Dec 16 14:05:32 GMT 2023 , Edited by admin on Sat Dec 16 14:05:32 GMT 2023
PRIMARY
FDA UNII
H0QPM375HE
Created by admin on Sat Dec 16 14:05:32 GMT 2023 , Edited by admin on Sat Dec 16 14:05:32 GMT 2023
PRIMARY